Skip to main content

St. Jude pediatric oncologist Dylan Graetz receives Young Investigator Award from ASCO

Dylan Graetz, M.D., M.P.H., a pediatric hematology-oncology fellow at St. Jude, has received a Young Investigator Award from the American Society of Clinical Oncology.

Memphis, Tennessee, June 18, 2020

Researcher in a red shirt sitting forward and smiling.

Dylan Graetz, M.D., M.P.H., a St. Jude research fellow, has been recognized by the ASCO for quality research in clinical oncology.

Dylan Graetz, M.D., M.P.H., a pediatric hematology-oncology fellow at St. Jude Children’s Research Hospital, has received a Young Investigator Award from the American Society of Clinical Oncology. The award provides funding to promising investigators to encourage and promote quality research in clinical oncology and help launch their careers.

Graetz’s research in Global Pediatric Medicine focuses on how culture affects communication and how that in turn affects outcomes for children with cancer. She is assessing the communication needs of patients and families in Guatemala at the time of diagnosis.

“I am very grateful to ASCO for supporting me as I work with partners in Guatemala to explore patient-centered communication in a limited-resource setting,” Graetz said. “Our goal is to understand and enhance current communication practices, ultimately ensuring that St. Jude Global partners can continue to provide optimal care to pediatric cancer patients around the world.”

Graetz completed medical training and earned a master’s of public health degree at the University of Connecticut. She completed her pediatric residency at the Children’s Hospital of Philadelphia. 

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 50 years ago. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food — because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude on social media at @stjuderesearch.

 
 
Close